Journal of Cancer Epidemiology and Prevention Open Access

Name of the Conference : Journal of Medical Oncology and Therapeutics, Journal of Cancer Immunology & Therapy, Journal of Clinical Oncology and Cancer Research

2nd International Conference on Cancer Science and Cancer Therapy is designed to create awareness in order to reduce the number of cancer cases and deaths and improve quality of life of the patients suffering from the deadly disease. This is done by implementing systematic, equitable and evidence-based strategies for early detection, diagnosis, prevention, palliation, and treatment using available resources. Join us during May 10-11, 2021 at Munich, Germany. Cancer Therapy 2021 Conference will help to reduce the cancer burden and improve services for cancer patients and their families.

Based on the recent report, worldwide cancer affects more than 10 million people every year and the incidence of deaths are projected to continue rising, with an estimated 13.1 million deaths in 2030 (about a 70% increase) around 22% of all deaths not related to communicable diseases. Rise in cancer research, increase in cancer prevalence and surge in association between pharmaceutical companies the core factors that enhance the growth of cancer therapeutics market.

From the basics of immunotherapies to the latest research results, from understanding the different treatment options to interpretation of new data and management of toxicities, this Cancer Therapy 2021 Conference brings together the communities in both translational and basic cancer research and cover the research studies exploring the genes that affect cancer risk and the genomics, fundamentals of cancer cells and the hormone responses, cell signalling, cancer controlling proteins and growth, novel diagnostic methods, immune treatments and new-generation molecular targeted therapies.

This annual Munich Cancer Therapy Conference is directed toward oncologists, cancer researchers, pharma companies, hospitals, physicians, Cancer therapist, cancer associations, organizations, hematologists, nurses, nurse practitioners, and pharmacists who are all involved in the treatment of patients with cancer. Immunologists, Radiotherapists, fellows, physician assistants, researchers, case managers, and other healthcare professionals who are interested in the cancer treatment are also welcome to participate.

The Cancer Therapy Conference YRF being organised with the sole intention of appreciating and encouraging young researchers (those under 33 years of age and early career researchers) to interact and learn from their seniors, to get a hands-on experience in the working of the society and mend the society with their stimulating ideas. Together with other initiatives emerged in many research areas of cancer, the young researchers forum marks the awareness and the desire of PhD students, postdoctoral fellows, trainees, junior faculty, young researchers, young engineers to play a vital role in the scientific progress.

With the fruitful synergistic interactions and discussions, learnings, partnerships and associations at this yearly meeting, we anticipate getting together to unveil the challenges by improvising the early diagnosis and detection of cancer research for better outcomes of patients. It is vital to dispel the myths that people wrongly believe, to inform the people about the signs and symptoms, importance of screening for early detection, recent treatments, and diagnostic techniques. Germany Cancer Therapy Conference is stepping ahead to create a platform to bring together the scientists, researchers from around the world fostering collaborations in the industry and the research community to centre their efforts on cancer research translation with an aim towards cancer free world.

Take this fabulous opportunity to learn, share your research and build invaluable associations or collaborations with fellow experts.